Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Sep 8, 2017
Company News
Acorda adopts shareholder rights plan
...accumulations of significant portions" of Acorda's stock. According to an SEC filing dated Aug. 29,
Scopia Capital Management
...
Read More
BioCentury
|
Sep 1, 2017
Financial News
Acorda adopts poison pill
...accumulations of significant portions" of Acorda's stock. According to an SEC filing dated Aug. 29,
Scopia Capital Management
...
Read More
BioCentury
|
Aug 11, 2017
Company News
Investor urges Acorda to sell
...In a letter,
Scopia Capital Management
LP urged the board of Acorda Therapeutics Inc. (NASDAQ:ACOR) to consider a...
Read More
BioCentury
|
Aug 7, 2017
Company News
Investor urges Acorda to sell
...In a letter ,
Scopia Capital Management
LP urged the board of Acorda Therapeutics Inc. (NASDAQ:ACOR) to consider...
Read More
Items per page:
10
1 - 4 of 4
BioCentury
|
Sep 8, 2017
Company News
Acorda adopts shareholder rights plan
...accumulations of significant portions" of Acorda's stock. According to an SEC filing dated Aug. 29,
Scopia Capital Management
...
Read More
BioCentury
|
Sep 1, 2017
Financial News
Acorda adopts poison pill
...accumulations of significant portions" of Acorda's stock. According to an SEC filing dated Aug. 29,
Scopia Capital Management
...
Read More
BioCentury
|
Aug 11, 2017
Company News
Investor urges Acorda to sell
...In a letter,
Scopia Capital Management
LP urged the board of Acorda Therapeutics Inc. (NASDAQ:ACOR) to consider a...
Read More
BioCentury
|
Aug 7, 2017
Company News
Investor urges Acorda to sell
...In a letter ,
Scopia Capital Management
LP urged the board of Acorda Therapeutics Inc. (NASDAQ:ACOR) to consider...
Read More
Items per page:
10
1 - 4 of 4
Previous page
Next page